PMGC Holdings Notifies Availability of NorthStrive Biosciences Phase III Program Update

PMGC Holdings Inc.

PMGC Holdings Inc.

ELAB

0.00
  • PMGC posted a press release on July 1, 2026, reporting positive Phase III results from NorthStrive’s AI drug discovery program with Yuva Biosciences.
  • In primary human skeletal muscle cells, four AI-selected small molecules increased ANT1 expression; top candidates showed up to 50% induction.
  • Program moves to confirmatory testing in a more mature skeletal muscle model to support further development.
  • Prior program update link: https://www.globenewswire.com/Tracker?data=13U5c9BRK6dFavgvrqrDHS0GzGp95yc1mAEyA7SvRPlhcP1fepjnd6x3ZhsCue8RJX6AbW5eGk6t9AX_iLxREEM20mChK_aMplFXMDOWK4U6cH-YglcEsjL_gf--v88UkhXQt3RqMoQANWCFTitto-NtjpPzOfJTTfdETUazbRONYiezb-mfzgNaY-LJ8_yfGsZLkmxg4cubirXLmwBFhTpAoLvqawjtHDpMl_h3sTcPl3COj6iruSC1jh1x_Raq


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010730PRIMZONEFULLFEED9755445) on July 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.